CompleWare and VIDA announce a joint marketing agreement promoting complementary respiratory services. Their partnership will deploy a best-in-class pulmonary platform and excellence in clinical trial management, with precision, ISO-certified core lab imaging.
September 8, 2017 (Coralville, IA) – Viewpoint Molecular Targeting, LLC, a University of Iowa start-up pharmaceutical company that has developed a novel therapy and companion diagnostic for metastatic melanoma, announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) Contract Award valued at $2 million from the National Cancer Institute (NCI) to support pre-clinical studies of its lead product, VMT-01.
September 6, 2017 (IOWA CITY, IA) – Viewpoint Molecular Targeting LLC, a University of Iowa spin-out company developing therapies and diagnostics for metastatic melanoma, recently placed first at the Iowa SBIR Showcase (Virtual SBIR Road Tour) pitch competition.
For the third year, the University of Iowa Office of the Vice President for Research and Economic Development (OVPR&ED) helped sponsor the Innovative Software Engineering (ISE) Coding Garage this summer, bringing together 15 high school students from the Iowa City area to create their own mobile apps. Because of the partnership between the Coralville-based ISE and OVPR&ED’s prototyping and 3D rendering resource, protostudios, the workshop was free to students, who met at the UI’s BioVentures Center in Coralville weekly for nine weeks.
University of Iowa startup and medical device developer iotaMotion Inc. has raised $2 million in a seed financing round to fuel the development of novel robotic systems for cochlear implantation surgery.
